Next |
home / stock / txmd / txmd message board
Subject | By | Source | When |
---|---|---|---|
look to put money back in stocks around Feburary.. | jablome | investorshub | 12/29/2022 5:14:48 PM |
SaltyMutt: TY for reminding me of TXMD. I haven't thought about it in a while. | SaltyMutt | investorshangout | 12/05/2022 9:10:03 PM |
znewcar1: $TXMD HOD5.84 28% v2,15m $5.695 f9,467,104 | znewcar1 | investorshangout | 12/05/2022 6:41:07 PM |
November 30? | JCB5 | investorshub | 12/05/2022 2:07:06 PM |
should see bankruptcy or buyout soon on nov. | magacrew2020 | investorshub | 11/25/2022 5:45:40 PM |
Sell em down | JCB5 | investorshub | 09/16/2022 12:23:33 AM |
Therapeutics MD GAAP EPS of $12.39, revenue of $28.6M | subslover | investorshub | 08/15/2022 12:10:25 PM |
TherapeuticsMD ($TXMD) Announces $15M Common and Preferred Stock | subslover | investorshub | 08/01/2022 12:36:19 PM |
Best read and explanation from both sides of | cash4 | investorshub | 07/13/2022 11:21:53 PM |
The option chain for $TXMD is crazy now, | cash4 | investorshub | 07/13/2022 6:32:17 PM |
What happened now? | JCB5 | investorshub | 07/13/2022 2:42:21 PM |
Who else other than EW in order to | cash4 | investorshub | 07/11/2022 8:01:50 PM |
Yes. Whos selling lower than offer? | JCB5 | investorshub | 07/11/2022 7:09:47 PM |
Couldn't have said better, what is the point | cash4 | investorshub | 07/11/2022 6:12:22 PM |
Agreed | JCB5 | investorshub | 07/11/2022 1:51:23 PM |
Analysts have set a mean price target of | cash4 | investorshub | 07/11/2022 9:51:18 AM |
If the deal goes through then the company | cash4 | investorshub | 07/05/2022 6:11:34 PM |
What happens if shareholders push back and refuse | JCB5 | investorshub | 07/04/2022 1:36:42 PM |
Very subtle accumulation for the last 2 weeks | cash4 | investorshub | 06/28/2022 10:31:07 PM |
Amended $Statement of Ownership: $Solicitation (sc 14d9/a) | cash4 | investorshub | 06/28/2022 10:29:41 PM |
News, Short Squeeze, Breakout and More Instantly...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This...
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's fut...